CA2947959C - Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples - Google Patents

Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples Download PDF

Info

Publication number
CA2947959C
CA2947959C CA2947959A CA2947959A CA2947959C CA 2947959 C CA2947959 C CA 2947959C CA 2947959 A CA2947959 A CA 2947959A CA 2947959 A CA2947959 A CA 2947959A CA 2947959 C CA2947959 C CA 2947959C
Authority
CA
Canada
Prior art keywords
seq
hpv
probe
sequence
primer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2947959A
Other languages
English (en)
French (fr)
Other versions
CA2947959A1 (en
Inventor
Klara Abravaya
Brian J. Erickson
Shihai X. Huang
Wai-Bing X. Mak
John A. Salituro
Ning Tang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Molecular Inc
Original Assignee
Abbott Molecular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Molecular Inc filed Critical Abbott Molecular Inc
Publication of CA2947959A1 publication Critical patent/CA2947959A1/en
Application granted granted Critical
Publication of CA2947959C publication Critical patent/CA2947959C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA2947959A 2008-09-30 2009-09-30 Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples Active CA2947959C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/241,119 US9090948B2 (en) 2008-09-30 2008-09-30 Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples
US12/241,119 2008-09-30
CA2738512A CA2738512C (en) 2008-09-30 2009-09-30 Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2738512A Division CA2738512C (en) 2008-09-30 2009-09-30 Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples

Publications (2)

Publication Number Publication Date
CA2947959A1 CA2947959A1 (en) 2017-01-13
CA2947959C true CA2947959C (en) 2018-04-17

Family

ID=41510739

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2947959A Active CA2947959C (en) 2008-09-30 2009-09-30 Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples
CA2738512A Active CA2738512C (en) 2008-09-30 2009-09-30 Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2738512A Active CA2738512C (en) 2008-09-30 2009-09-30 Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples

Country Status (7)

Country Link
US (3) US9090948B2 (enExample)
EP (3) EP3202920A1 (enExample)
JP (2) JP5795259B2 (enExample)
CA (2) CA2947959C (enExample)
ES (1) ES2628432T3 (enExample)
RU (1) RU2530550C2 (enExample)
WO (1) WO2010039809A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2313641A1 (en) * 1997-12-12 1999-06-24 Digene Corporation Universal collection medium
US7601497B2 (en) 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
JP2011518333A (ja) * 2008-04-17 2011-06-23 キアジェン ゲイサーズバーグ インコーポレイテッド 標的核酸の存在を判別するための合成プローブを用いた組成物、方法、およびキット
TWI419974B (zh) 2008-10-27 2013-12-21 Qiagen Gaithersburg Inc 於自動平台上之快速結果雜交捕捉法
AU2010242867B2 (en) * 2009-05-01 2016-05-12 Qiagen Gaithersburg, Inc. A non-target amplification method for detection of RNA splice-forms in a sample
EP2478087B1 (en) 2009-09-14 2017-01-18 QIAGEN Gaithersburg, Inc. Compositions and methods for recovery of nucleic acids or proteins from tissue samples fixed in cytology media
JP2013517803A (ja) 2010-01-29 2013-05-20 キアジェン ゲイサーズバーグ インコーポレイテッド サンプル中のｈｐｖの存在を決定および確認する方法
WO2011094514A1 (en) * 2010-01-29 2011-08-04 Qiagen Gaithersburg, Inc. Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
EP2572001A2 (en) 2010-05-19 2013-03-27 QIAGEN Gaithersburg, Inc. Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
CA2799205A1 (en) 2010-05-25 2011-12-01 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes
EP2678442B1 (en) 2011-02-24 2019-01-16 QIAGEN Gaithersburg, Inc. Materials and methods for detection of hpv nucleic acid
CN103409560A (zh) * 2013-08-19 2013-11-27 潘晓静 一种广谱、高效、经济的高危人乳头状瘤病毒的pcr检测方法
KR101951172B1 (ko) * 2014-11-07 2019-02-22 주식회사 파나진 인유두종바이러스의 유전자형 검출을 위한 ρνα 프로브, 키트 및 방법
CN105400782B (zh) * 2015-12-09 2018-09-07 中国农业科学院兰州兽医研究所 同时鉴定三种猪流行性腹泻病毒毒株的引物组合和通用型半套式rt-pcr方法
CN107130059B (zh) * 2017-06-28 2018-07-20 广州市宝创生物技术有限公司 一种新型的21种人乳头瘤病毒亚型分型试剂盒和方法
CN107130058B (zh) * 2017-06-28 2018-08-03 广州市宝创生物技术有限公司 一种新型的9种人乳头瘤病毒亚型分型试剂盒和方法
CN107828920B (zh) * 2017-12-18 2021-08-06 苏州国科闻普生物科技有限公司 对多种高危型人乳头瘤病毒实现分型的试剂盒
CN107828919A (zh) * 2017-12-18 2018-03-23 苏州国科闻普生物科技有限公司 适用于四荧光通道的单管检测多个高危型hpv的试剂盒
CN107988432A (zh) * 2017-12-18 2018-05-04 苏州国科闻普生物科技有限公司 在单管反应中同时检测多个高危型人乳头瘤病毒的试剂盒
WO2020132090A1 (en) 2018-12-18 2020-06-25 Abbott Molecular Inc. Assay for detecting human papilloma virus (hpv)
CN110570202B (zh) * 2019-09-02 2022-06-03 杭州趣链科技有限公司 一种基于分片技术的混合共识方法
US20220017978A1 (en) * 2020-07-14 2022-01-20 Northwestern University Virofind: a novel platform for detection and discovery of the entire virogenome in clinical samples
WO2023076639A1 (en) * 2021-10-28 2023-05-04 Jung Joo Moon Primer, probe and controls for detection and discrimination of covid-19 and other coronaviruses diagnostic assay for the human virus causing covid-19-cov-2(covid-19) and its variants
CN120041610B (zh) * 2025-02-20 2025-09-12 广州市金圻睿生物科技有限责任公司 一种用于检测生殖道感染相关病原体及其耐药基因的引物组合物及其应用

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US5310652A (en) 1986-08-22 1994-05-10 Hoffman-La Roche Inc. Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription
US4849332A (en) 1987-05-26 1989-07-18 Life Technologies, Inc. Human papillomavirus 35 nucleic acid hybridization probes and methods for employing the same
US5585481A (en) 1987-09-21 1996-12-17 Gen-Probe Incorporated Linking reagents for nucleotide probes
US5185439A (en) 1987-10-05 1993-02-09 Gen-Probe Incorporated Acridinium ester labelling and purification of nucleotide probes
US5130238A (en) 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
US5447839A (en) 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
US5234809A (en) 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
NL9000134A (nl) 1990-01-19 1991-08-16 Stichting Res Fonds Pathologie Primers en werkwijze voor het detecteren van humaan papilloma virus genotypen m.b.v. pcr.
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
CA2052413C (en) * 1990-09-28 2004-07-13 Jeffrey L. Joseph Nucleotides sequences useful as type-specific probes, pcr primers and lcr probes for the amplifications and detection of human papilloma virus, and related kits and methods
AU8997991A (en) 1991-01-31 1992-08-06 Becton Dickinson & Company Exonuclease mediated strand displacement amplification
US5455166A (en) 1991-01-31 1995-10-03 Becton, Dickinson And Company Strand displacement amplification
US5279309A (en) 1991-06-13 1994-01-18 International Business Machines Corporation Signaling device and method for monitoring positions in a surgical operation
US5411875A (en) 1991-11-01 1995-05-02 University Of Iowa Research Foundation Method for retrieval of unknown flanking DNA sequence
US5270184A (en) 1991-11-19 1993-12-14 Becton, Dickinson And Company Nucleic acid target generation
US5344166A (en) 1993-09-30 1994-09-06 Microcentric Corporation Jaw assembly for chucks
US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
WO1995022626A1 (en) 1994-02-21 1995-08-24 Stichting Researchfonds Pathologie Human papilloma virus detection in a nucleic acid amplification process using general primers
US5487792A (en) 1994-06-13 1996-01-30 Midwest Research Institute Molecular assemblies as protective barriers and adhesion promotion interlayer
US6265154B1 (en) * 1996-10-25 2001-07-24 Abbott Laboratories Nucleic acid primers and probes for detecting oncogenic human papillomaviruses
CA2270132A1 (en) * 1996-11-06 1998-05-14 Sequenom, Inc. Dna diagnostics based on mass spectrometry
US5846726A (en) 1997-05-13 1998-12-08 Becton, Dickinson And Company Detection of nucleic acids by fluorescence quenching
DE69806024T2 (de) 1997-09-16 2003-02-13 Delft Diagnostic Laboratory B.V., Delft Erkennung und identifizierung von menschlichem papillomavirus durch pcr und typ-spezifischer reverser hybridisierung
US6045993A (en) 1998-05-30 2000-04-04 Visible Genetics Inc. Method, reagent and kit for genotyping of human papillomavirus
GB9826247D0 (en) * 1998-11-30 1999-01-20 Nycomed Pharma As Method
US6136599A (en) 1998-12-10 2000-10-24 Bayer Corporation Human hybrid host cell for mammalian gene expression
US6235504B1 (en) 1999-01-11 2001-05-22 The Rockefeller University Methods for identifying genomic equivalent markers and their use in quantitating cells and polynucleotide sequences therein
US6277581B1 (en) 1999-03-01 2001-08-21 Lankenau Medical Research Center ODC allelic analysis method for assessing carcinogenic susceptibility
DE60141205D1 (de) * 2000-04-03 2010-03-18 Cytyc Corp Nachweis und typisierung des papillomavirus mittels pna-sonden
US7019129B1 (en) 2000-05-09 2006-03-28 Biosearch Technologies, Inc. Dark quenchers for donor-acceptor energy transfer
AU7878301A (en) 2000-08-23 2002-03-04 Takara Shuzo Co Method of amplifying nucleic acid
US7070995B2 (en) * 2001-04-11 2006-07-04 City Of Hope CE7-specific redirected immune cells
EP1302550A1 (en) 2001-10-10 2003-04-16 King Car Food Industrial Co., Ltd. Method and detector for identifying subtypes of human papilloma viruses
EP1452593B1 (en) * 2001-11-14 2009-04-08 Toyo Boseki Kabushiki Kaisha Dna synthesis promoters, dna polymerase-associated factors and utilization thereof
EP2272988A3 (en) 2002-01-07 2011-06-15 Norchip A/S Method for detecting human papillomavirus mRNA
HUP0200981A3 (en) 2002-03-14 2004-06-28 Genoid Kft Pcr reactions with hybridizing probes using primers with broad genotype-specificity for detection of human papilloma-viruses and typing amplificates by using specifically hybridizing oligonucleotides
JP4076165B2 (ja) * 2004-02-05 2008-04-16 インターナショナル・ビジネス・マシーンズ・コーポレーション 管理装置、収納カセット、現金自動預け払い機、情報処理システム、管理方法、及び制御方法
DE602005009324D1 (de) 2005-04-06 2008-10-09 Maurice Stroun Methode zur Krebsdiagnose mittels Nachweis von DNA und RNA im Kreislauf
GR1005451B (el) 2005-09-20 2007-02-21 Medicon Hellas A.E. Μεθοδος εντοπισμου διαφορων ενος νουκλεοτιδιου σεμια αλληλουχια νουκλεοτιδιων με τη χρηση ξηρων/λυοφιλοποιημενων αντιδραστηριων
KR100702415B1 (ko) 2006-03-03 2007-04-09 안웅식 올리고 핵산 탐침 비드 어레이를 이용한 인유두종바이러스검출 키트 및 방법
US20080113358A1 (en) 2006-07-28 2008-05-15 Ravi Kapur Selection of cells using biomarkers
US20100167280A1 (en) 2006-08-11 2010-07-01 Ivan Brukner Oligonucleotides for discriminating related nucleic acid sequences
EP2034032A1 (en) * 2007-08-28 2009-03-11 DKFZ Deutsches Krebsforschungszentrum, Stiftung des Öffentlichen Rechts Composition comprising an oligonucleotide mixture for improved detection of human papillomavirus genotypes

Also Published As

Publication number Publication date
ES2628432T3 (es) 2017-08-02
JP2016028574A (ja) 2016-03-03
EP3202920A1 (en) 2017-08-09
JP6177844B2 (ja) 2017-08-09
EP2565280A3 (en) 2013-07-03
US9090948B2 (en) 2015-07-28
JP5795259B2 (ja) 2015-10-14
CA2738512A1 (en) 2010-04-08
US20150361482A1 (en) 2015-12-17
US10689685B2 (en) 2020-06-23
US20180044717A1 (en) 2018-02-15
CA2947959A1 (en) 2017-01-13
EP2565280B1 (en) 2017-03-15
EP2565280A2 (en) 2013-03-06
EP2352843A2 (en) 2011-08-10
US20100081124A1 (en) 2010-04-01
RU2011117297A (ru) 2012-11-10
RU2530550C2 (ru) 2014-10-10
CA2738512C (en) 2017-08-08
WO2010039809A2 (en) 2010-04-08
WO2010039809A3 (en) 2010-08-05
US9803232B2 (en) 2017-10-31
JP2012504414A (ja) 2012-02-23

Similar Documents

Publication Publication Date Title
US10689685B2 (en) Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples
US20050175987A1 (en) Fluorescent multiplex hpv pcr assays using multiple fluorophores
EP1847616B1 (en) Neisseria gonorrhoeae specific oligonucleotide sequences
EP1806410A2 (en) Fluorescent multiplex HPV PCR assays using multiple fluorophores
US20100261154A1 (en) Primers and probes for detecting hepatitis c virus
EP1945818B1 (en) Chlamydia trachomatis specific oligonucleotide sequences
JP2009515545A (ja) 方法
US20100003665A1 (en) Real-time HPV PCR Assays
JP7582674B2 (ja) 牛白血病ウイルスを検出するためのキット
US20100203496A1 (en) Fluorescent Multiplex HPV PCR Assays

Legal Events

Date Code Title Description
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 15TH ANNIV.) - STANDARD

Year of fee payment: 15

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240808

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240808

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 16TH ANNIV.) - STANDARD

Year of fee payment: 16

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250811

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251008